Greenup Street Wealth Management LLC Has $1.46 Million Holdings in UnitedHealth Group Incorporated $UNH

Greenup Street Wealth Management LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.5% during the second quarter, HoldingsChannel.com reports. The firm owned 4,674 shares of the healthcare conglomerate’s stock after acquiring an additional 242 shares during the quarter. Greenup Street Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,458,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Vanguard Group Inc. grew its position in shares of UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of UnitedHealth Group by 2.5% during the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after acquiring an additional 196,696 shares during the period. Nuveen LLC bought a new stake in shares of UnitedHealth Group during the 1st quarter worth approximately $3,846,764,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of UnitedHealth Group by 13.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after acquiring an additional 847,054 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of a number of recent analyst reports. UBS Group reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Jefferies Financial Group increased their price objective on shares of UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research note on Friday. Truist Financial increased their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Finally, JPMorgan Chase & Co. increased their price objective on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Eighteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $385.13.

UnitedHealth Group Price Performance

UNH stock opened at $364.31 on Tuesday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a fifty day moving average price of $331.62 and a 200-day moving average price of $341.12. The company has a market capitalization of $329.95 billion, a P/E ratio of 15.78, a PEG ratio of 2.31 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the company earned $6.80 earnings per share. The company’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.